Faggiani Ilaria, Fanizza Jacopo, D'Amico Ferdinando, Allocca Mariangela, Zilli Alessandra, Parigi Tommaso Lorenzo, Barchi Alberto, Danese Silvio, Furfaro Federica
Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, 20132 Milan, Italy.
Gastroenterology and Endoscopy, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Biomedicines. 2024 Aug 13;12(8):1839. doi: 10.3390/biomedicines12081839.
The inflammatory bowel diseases (IBDs) are systemic conditions that affect not only the gastrointestinal tract but also other parts of the body. The presence of extraintestinal manifestations can significantly impact the quality of life in IBD patients. Peripheral arthritis, episcleritis, and erythema nodosum are frequently associated with active intestinal inflammation and often improve with standard treatment targeting intestinal inflammation. In contrast, anterior uveitis, ankylosing spondylitis, and primary sclerosing cholangitis typically occur independently of disease flares. The incidence of these conditions in individuals with IBD can reach up to 50% of patients over the course of their lifetime. In addition, some advanced therapies utilized for the treatment of IBD potentially result in side effects that may resemble extraintestinal manifestations. This review provides a thorough analysis of the pathophysiology and treatment of extraintestinal manifestations associated with Crohn's disease and ulcerative colitis.
炎症性肠病(IBD)是一种全身性疾病,不仅会影响胃肠道,还会影响身体的其他部位。肠外表现的存在会显著影响IBD患者的生活质量。外周关节炎、巩膜外层炎和结节性红斑常与肠道炎症活动相关,通常通过针对肠道炎症的标准治疗得以改善。相比之下,前葡萄膜炎、强直性脊柱炎和原发性硬化性胆管炎通常独立于疾病发作而发生。在IBD患者中,这些疾病的发病率在其一生中可达患者总数的50%。此外,一些用于治疗IBD的先进疗法可能会产生类似于肠外表现的副作用。本综述对与克罗恩病和溃疡性结肠炎相关的肠外表现的病理生理学和治疗进行了全面分析。